Skip to main content

Table 14 Bivariate analysis: clinical characteristics and need for pressors

From: Serologic and urinary characteristics of laboratory-confirmed genitourinary tuberculosis at a tertiary hospital in the Philippines

Characteristic Category Mortality p value
Survived Expired
Count Row % Count Row %
Gender Male 8 15.1 45 84.9 1.000
Female 10 15.4 55 84.6
Age 0 months to 1 year 1 100.0 0 0.0 0.019
1–5 years 2 66.7 1 33.3
6–10 years 0 0.0 4 100.0
11–18 years 4 21.1 15 78.9
19–29 years 5 21.7 18 78.3
30–49 years 3 8.1 34 91.9
50–69 years 2 7.4 25 92.6
≥ 70 years 1 25.0 3 75.0
Marital status Single/widowed 13 17.6 61 82.4 0.436
Married 5 11.4 39 88.6
Occupation Employed 3 15.0 17 85.0 0.762
Unemployed 8 13.1 53 86.9
Not applicable 6 21.4 22 78.6
Unspecified 1 11.1 8 88.9
Location City 10 16.1 52 83.9 0.898
Province 7 13.7 44 86.3
Unspecified 1 20.0 4 80.0
Co-morbidity Yes 8 14.5 47 85.5 1.000
No 10 15.9 53 84.1
Diabetes mellitus Yes 0 0.0 5 100.0 1.000
No 18 15.9 95 84.1
Hypertension Yes 0 0.0 13 100.0 0.214
No 18 17.1 87 82.9
Chronic kidney disease Yes 2 33.3 4 66.7 0.227
No 16 14.3 96 85.7
History of urolithiasis Yes 2 25.0 6 75.0 0.352
No 16 14.5 94 85.5
Malignancy Yes 0 0.0 1 100.0 1.000
No 18 15.4 99 84.6
HIV/AIDS Yes 2 15.4 11 84.6 1.000
No 16 15.2 89 84.8
Steroid use Yes 3 33.3 6 66.7 0.139
No 15 13.8 94 86.2
Systemic lupus erythematosus Yes 2 25.0 6 75.0 0.352
No 16 14.5 94 85.5
Nephrotic syndrome Yes 1 100.0 0 0.0 0.153
No 17 14.5 100 85.5
Cerebrovascular disease Yes 0 0.0 1 100.0 1.000
No 18 15.4 99 84.6
Coronary artery disease No 18 15.3 100 84.7 No test*
Heart failure Yes 0 0.0 2 100.0 1.000
No 18 15.5 98 84.5
COPD Yes 0 0.0 1 100.0 1.000
No 18 15.4 99 84.6
Bronchial asthma Yes 0 0.0 2 100.0 1.000
No 18 15.5 98 84.5
Spina bifida No 18 15.3 100 84.7 No test*
RTA Type 1 Yes 0 0.0 1 100.0 1.000
No 18 15.4 99 84.6
Previous TB Yes 0 0.0 14 100.0 0.124
No 18 17.3 86 82.7
Other organ involvement of TB Yes 15 21.4 55 78.6 0.035
No 3 6.3 45 93.8
Pulmonary TB Yes 13 21.0 49 79.0 0.079
No 5 8.9 51 91.1
Gastrointestinal TB Yes 10 32.3 21 67.7 0.006
No 8 9.2 79 90.8
Abdominopelvic TB Yes 3 23.1 10 76.9 0.417
No 15 14.3 90 85.7
CNS TB Yes 3 37.5 5 62.5 0.102
No 15 13.6 95 86.4
Bone TB Yes 1 25.0 3 75.0 0.489
No 17 14.9 97 85.1
Cutaneous/Wound TB Yes 3 100.0 0 0.0 0.003
No 15 13.0 100 87.0
TB Adenitis Yes 1 10.0 9 90.0 1.000
No 17 15.7 91 84.3
Ear TB Yes 1 50.0 1 50.0 0.283
No 17 14.7 99 85.3
Psoas TB Yes 1 50.0 1 50.0 0.283
No 17 14.7 99 85.3
Dysuria Yes 2 28.6 5 71.4 0.603
No 16 16.7 80 83.3
Hematuria Yes 1 11.1 8 88.9 1.000
No 17 18.1 77 81.9
Urinary retention Yes 0 0.0 1 100.0 1.000
No 18 17.6 84 82.4
Flank pain Yes 1 8.3 11 91.7 0.687
No 17 18.7 74 81.3
Inguinal pain Yes 0 0.0 1 100.0 1.000
No 18 17.6 84 82.4
Umbilical discharge Yes 0 0.0 3 100.0 1.000
No 18 18.0 82 82.0
Fistula (uretero-cutaneous fistula) Yes 0 0.0 1 100.0 1.000
No 18 17.6 84 82.4
Scrotal discharge Yes 0 0.0 1 100.0 1.000
No 18 17.6 84 82.4
Double J stent reinsertion Yes 0 0.0 1 100.0 1.000
No 18 17.6 84 82.4
Pedal edema Yes 1 25.0 3 75.0 0.542
No 17 17.2 82 82.8
Fever Yes 0 0.0 7 100.0 0.349
No 18 18.8 78 81.3
Weakness Yes 2 13.3 13 86.7 1.000
No 16 18.2 72 81.8
Abdominal pain Yes 3 27.3 8 72.7 0.402
No 15 16.3 77 83.7
Abdominal/pelvic mass on diagnostic Yes 0 0.0 4 100.0 1.000
No 18 18.2 81 81.8
Vaginal bleeding Yes 0 0.0 2 100.0 1.000
No 18 17.8 83 82.2
Difficulty of breathing Yes 4 30.8 9 69.2 0.235
No 14 15.6 76 84.4
Others Yes 4 36.4 7 63.6 0.098
No 14 15.2 78 84.8
  1. Bold values indicate statistically significant differences
  2. *No test was done since all patients were classified under the No category
  3. COPD chronic obstructive pulmonary disease, HIV/AIDS human immunodeficiency virus or acquired immunodeficiency syndrome, RTA Type 1 renal tubular acidosis Type 1, TB tuberculosis, y year